Goldman Sachs’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-44,131
| Closed | -$7K | – | 4704 |
|
|
2016
Q3 | $7K | Buy |
44,131
+2,220
| +5% | +$352 | ﹤0.01% | 4509 |
|
|
2016
Q2 | $13K | Sell |
41,911
-12,255
| -23% | -$3.8K | ﹤0.01% | 4449 |
|
|
2016
Q1 | $10K | Buy |
54,166
+28,372
| +110% | +$5.24K | ﹤0.01% | 4441 |
|
|
2015
Q4 | $45K | Buy |
25,794
+13,973
| +118% | +$24.4K | ﹤0.01% | 4208 |
|
|
2015
Q3 | $22K | Sell |
11,821
-13,328
| -53% | -$24.8K | ﹤0.01% | 4454 |
|
|
2015
Q2 | $59K | Sell |
25,149
-5,961
| -19% | -$14K | ﹤0.01% | 4411 |
|
|
2015
Q1 | $136K | Sell |
31,110
-9,855
| -24% | -$43.1K | ﹤0.01% | 4058 |
|
|
2014
Q4 | $197K | Sell |
40,965
-6,698
| -14% | -$32.2K | ﹤0.01% | 3978 |
|
|
2014
Q3 | $198K | Buy |
47,663
+9,810
| +26% | +$40.8K | ﹤0.01% | 3958 |
|
|
2014
Q2 | $223K | Sell |
37,853
-14,213
| -27% | -$83.7K | ﹤0.01% | 3908 |
|
|
2014
Q1 | $332K | Sell |
52,066
-2,799
| -5% | -$17.8K | ﹤0.01% | 3625 |
|
|
2013
Q4 | $522K | Buy |
+54,865
| New | +$522K | ﹤0.01% | 3398 |
|